Garret A. FitzGerald

70.4k total citations · 20 hit papers
488 papers, 50.4k citations indexed

About

Garret A. FitzGerald is a scholar working on Pharmacology, Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Garret A. FitzGerald has authored 488 papers receiving a total of 50.4k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Pharmacology, 106 papers in Biochemistry and 105 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Garret A. FitzGerald's work include Inflammatory mediators and NSAID effects (189 papers), Eicosanoids and Hypertension Pharmacology (101 papers) and Antiplatelet Therapy and Cardiovascular Diseases (83 papers). Garret A. FitzGerald is often cited by papers focused on Inflammatory mediators and NSAID effects (189 papers), Eicosanoids and Hypertension Pharmacology (101 papers) and Antiplatelet Therapy and Cardiovascular Diseases (83 papers). Garret A. FitzGerald collaborates with scholars based in United States, Italy and United Kingdom. Garret A. FitzGerald's co-authors include John A. Lawson, Emanuela Ricciotti, Carlo Patrono, Domenico Praticò, Joshua Rokach, Kathy K. Griendling, Desmond J. Fitzgerald, Tilo Großer, Francesca Catella and Shiv Kapoor and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Garret A. FitzGerald

481 papers receiving 48.7k citations

Hit Papers

Prostaglandins and Inflammation 1983 2026 1997 2011 2011 2001 1999 2001 1986 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prostaglandins and Inflammation
    2011 2.8k citations Emanuela Ricciotti, Garret A. FitzGerald profile →
  2. The Coxibs, Selective Inhibitors of Cyclooxygenase-2
    2001 1.2k citations Garret A. FitzGerald, Carlo Patrono profile →
  3. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
    1999 1.0k citations Shiv Kapoor, John A. Lawson et al. Proceedings of the National Academy of Sciences profile →
  4. Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
    2001 1.0k citations Shiv Kapoor, Garret A. FitzGerald et al. profile →
  5. Platelet Activation in Unstable Coronary Disease
    1986 920 citations Garret A. FitzGerald et al. profile →
  6. A Functional Genomics Strategy Reveals Rora as a Component of the Mammalian Circadian Clock
    2004 870 citations Trey K. Sato, Satchidananda Panda et al. Neuron profile →
  7. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
    2007 862 citations Tilo Großer, Garret A. FitzGerald et al. profile →
  8. BMAL1 and CLOCK, Two Essential Components of the Circadian Clock, Are Involved in Glucose Homeostasis
    2004 840 citations R. Daniel Rudic, Peter McNamara et al. profile →
  9. Oxidative Stress and Cardiovascular Injury
    2003 775 citations Garret A. FitzGerald et al. Circulation profile →
  10. Coxibs and Cardiovascular Disease
    2004 704 citations Garret A. FitzGerald profile →
  11. Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
    2002 667 citations Yan Cheng, Tilo Großer et al. profile →
  12. Oxidative Stress and Cardiovascular Injury
    2003 598 citations Garret A. FitzGerald et al. Circulation profile →
  13. Understanding multicellular function and disease with human tissue-specific networks
    2015 562 citations Emanuela Ricciotti, Garret A. FitzGerald et al. profile →
  14. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    1983 540 citations Garret A. FitzGerald, John A. Lawson et al. Journal of Clinical Investigation profile →
  15. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment
    1991 470 citations Garret A. FitzGerald et al. The FASEB Journal profile →
  16. Dose-Related Kinetics of Aspirin
    1984 434 citations Garret A. FitzGerald et al. profile →
  17. Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock
    2015 408 citations Garret A. FitzGerald et al. Proceedings of the National Academy of Sciences profile →
  18. Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
    1984 406 citations Garret A. FitzGerald et al. profile →
  19. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
    1983 382 citations Garret A. FitzGerald, Carlo Patrono et al. Circulation profile →
  20. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
    2022 118 citations Garret A. FitzGerald et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garret A. FitzGerald United States 115 14.4k 11.4k 9.9k 9.0k 7.9k 488 50.4k
John R. Vane United Kingdom 113 24.7k 1.7× 13.2k 1.2× 12.3k 1.2× 18.4k 2.0× 11.9k 1.5× 468 63.3k
Jason D. Morrow United States 113 7.9k 0.6× 12.7k 1.1× 2.6k 0.3× 8.1k 0.9× 6.5k 0.8× 404 42.4k
Bart Staels France 147 5.0k 0.4× 41.5k 3.6× 6.0k 0.6× 18.2k 2.0× 5.8k 0.7× 789 78.9k
Yūji Matsuzawa Japan 123 4.0k 0.3× 16.7k 1.5× 16.7k 1.7× 25.2k 2.8× 2.2k 0.3× 700 80.5k
Gökhan S. Hotamışlıgil United States 105 3.2k 0.2× 26.3k 2.3× 6.5k 0.7× 24.3k 2.7× 3.3k 0.4× 178 71.9k
Joseph Loscalzo United States 117 2.0k 0.1× 18.0k 1.6× 10.1k 1.0× 11.9k 1.3× 4.1k 0.5× 614 55.3k
David G. Harrison United States 134 2.3k 0.2× 14.1k 1.2× 20.4k 2.1× 23.3k 2.6× 7.3k 0.9× 400 60.5k
Frank J. Gonzalez United States 171 6.8k 0.5× 56.6k 5.0× 3.5k 0.4× 16.8k 1.9× 10.3k 1.3× 1.3k 119.2k
Friedrich C. Luft Germany 112 3.8k 0.3× 12.8k 1.1× 16.9k 1.7× 8.8k 1.0× 2.2k 0.3× 1.1k 50.6k
Robert H. Eckel United States 82 2.9k 0.2× 8.7k 0.8× 14.7k 1.5× 16.8k 1.9× 1.4k 0.2× 242 65.3k

Countries citing papers authored by Garret A. FitzGerald

Since Specialization
Citations

This map shows the geographic impact of Garret A. FitzGerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garret A. FitzGerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garret A. FitzGerald more than expected).

Fields of papers citing papers by Garret A. FitzGerald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garret A. FitzGerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garret A. FitzGerald. The network helps show where Garret A. FitzGerald may publish in the future.

Co-authorship network of co-authors of Garret A. FitzGerald

This figure shows the co-authorship network connecting the top 25 collaborators of Garret A. FitzGerald. A scholar is included among the top collaborators of Garret A. FitzGerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garret A. FitzGerald. Garret A. FitzGerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brooks, Thomas G., Jordana B. Cohen, Raymond R. Townsend, et al.. (2024). Prognostic utility of rhythmic components in 24-h ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidity. Journal of Human Hypertension. 38(5). 420–429. 5 indexed citations
3.
He, Yan, Ronan Lordan, Amruta Naik, et al.. (2023). Circadian disruption in lung fibroblasts enhances NF‐κB activity to exacerbate neutrophil recruitment. The FASEB Journal. 37(2). e22753–e22753. 14 indexed citations
4.
Skarke, Carsten, Ronan Lordan, Amruta Naik, et al.. (2023). Modulation of the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination by Nonsteroidal Anti-Inflammatory Drugs. Journal of Pharmacology and Experimental Therapeutics. 386(2). 198–204. 1 indexed citations
5.
Naik, Amruta, Utham K. Valekunja, Soon Yew Tang, et al.. (2023). Circadian regulation of lung repair and regeneration. JCI Insight. 8(16). 7 indexed citations
6.
Lordan, Ronan, et al.. (2023). The Circadian Biology of Heart Failure. Circulation Research. 132(2). 223–237. 38 indexed citations
7.
Markosyan, Nune, Jinyang Li, Yu Sun, et al.. (2019). Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2). Journal of Clinical Investigation. 129(9). 3594–3609. 114 indexed citations
8.
FitzGerald, Garret A.. (2014). IP Policy Forum: Need for New IP Approaches to Facilitate Collaborative (Academic-Industrial) Drug Development. 18(1). 21.
9.
Musiek, Erik S., Miranda M. Lim, Guangrui Yang, et al.. (2013). Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. Journal of Clinical Investigation. 123(12). 5389–5400. 412 indexed citations
10.
Paschos, Georgios K. & Garret A. FitzGerald. (2013). Insulin Tolerance Test and Hyperinsulinemic-euglycemic Clamp. BIO-PROTOCOL. 3(10).
11.
Großer, Tilo, Susanne Fries, John A. Lawson, et al.. (2012). Drug Resistance and Pseudoresistance. Circulation. 127(3). 377–385. 132 indexed citations
12.
Garza, Luis A., Yaping Liu, Zaixin Yang, et al.. (2012). Prostaglandin D 2 Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia. Science Translational Medicine. 4(126). 126ra34–126ra34. 208 indexed citations
13.
Li, Xuanwen, Susanne Fries, Emanuela Ricciotti, et al.. (2010). Abstract 16834: Assessment of The Pharmacological Response to Aspirin by Quantitation of Platelet Cyclooxygenase Acetylation.. Circulation. 122(1-2). 98–103. 1 indexed citations
14.
Yu, Ying, Margaret B. Lucitt, Jane Stubbe, et al.. (2009). Prostaglandin F 2α elevates blood pressure and promotes atherosclerosis. Proceedings of the National Academy of Sciences. 106(19). 7985–7990. 85 indexed citations
15.
Sato, Trey K., Satchidananda Panda, Loren Miraglia, et al.. (2004). A Functional Genomics Strategy Reveals Rora as a Component of the Mammalian Circadian Clock. Neuron. 43(4). 527–537. 870 indexed citations breakdown →
16.
McNamara, Peter, Sang‐Beom Seo, R. Daniel Rudic, et al.. (2001). Regulation of CLOCK and MOP4 by Nuclear Hormone Receptors in the Vasculature. Cell. 105(7). 877–889. 369 indexed citations
17.
Vezza, Roberta, Joshua Rokach, & Garret A. FitzGerald. (2001). Prostaglandin F2αReceptor-Dependent Regulation of Prostaglandin Transport. Molecular Pharmacology. 59(6). 1506–1513. 13 indexed citations
18.
Barry, Órla P., Marcelo G. Kazanietz, Domenico Praticò, & Garret A. FitzGerald. (1999). Arachidonic Acid in Platelet Microparticles Up-regulates Cyclooxygenase-2-dependent Prostaglandin Formation via a Protein Kinase C/Mitogen-activated Protein Kinase-dependent Pathway. Journal of Biological Chemistry. 274(11). 7545–7556. 204 indexed citations
19.
Praticò, Domenico, et al.. (1998). Chronic Obstructive Pulmonary Disease Is Associated with an Increase in Urinary Levels of Isoprostane F2 α-III, an Index of Oxidant Stress. American Journal of Respiratory and Critical Care Medicine. 158(6). 1709–1714. 209 indexed citations
20.
Patrono, Carlo, Barry S. Coller, James E. Dalen, et al.. (1998). The Relationships Among Dose, Effectiveness, and Side Effects. CHEST Journal. 114(5). 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John R. Vane Breakdown of academic impact, for papers by Jason D. Morrow Breakdown of academic impact, for papers by Bart Staels Breakdown of academic impact, for papers by Yūji Matsuzawa Breakdown of academic impact, for papers by Gökhan S. Hotamışlıgil Breakdown of academic impact, for papers by Joseph Loscalzo Breakdown of academic impact, for papers by David G. Harrison Breakdown of academic impact, for papers by Frank J. Gonzalez Breakdown of academic impact, for papers by Friedrich C. Luft Breakdown of academic impact, for papers by Robert H. Eckel
Rankless by CCL
2026